EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Physicochemical Standardization, LC-MS/MS Phytochemical Characterization, and In Vitro Aldose Reductase Inhibitory Activity of Ayurvedic Formulation Chandraprabha Vati

Priya Mishra, Deepti Sharma, Manish M. Wanjari, Pushpendra Kannojia, Shyam Babu Singh

Journal of Integrative and Translational Biomedicine · 2026

DOI: 10.67316/jintb.v1.i3.57 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative and Translational Biomedicine, 2026. Verfasst von Priya Mishra und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chandraprabha Vati (CPV) is an Ayurvedic polyherbal formulation, traditionally used for diabetes-like conditions, urinary disorders, reproductive ailments, and as a rejuvenative, but its phytochemical profile is poorly validated. This study aims to establish the physicochemical standardization, identify key phytoconstituents, and evaluate in vitro aldose reductase inhibitory activity.

Methods

Preliminary physicochemical and phytochemical screening was employed following total phenolic, flavonoid, alkaloid, and saponin contents using spectrophotometric methods. LC–MS/MS identified key bioactive constituents. Aldose reductase inhibitory activity was assessed spectrophotometrically in vitro.

Results

Physicochemical parameters (total ash 24.89%, acid-insoluble ash 13.45%, alcohol-soluble extractive 25.33%, water-soluble extractive 54.08%, moisture 5.30%, pH 5.427) confirmed formulation authenticity. Phenolics and flavonoids were the dominant quantified phytomolecules. LC–MS identified sixteen compounds, with gallic acid (~2980 mg/kg), piperine (~422 mg/kg), and ellagic acid (~396 mg/kg). CPV exhibited concentration-dependent aldose reductase inhibition (IC₅₀ = 1.163 µg/mL), compared to quercetin (IC₅₀ = 0.620 µg/mL).

Conclusion

CPV demonstrates physicochemical quality, a diverse phytochemical profile, and substantial aldose reductase inhibitory activity. These findings substantiate CPV traditional use and support its potential as a candidate for mitigating diabetes-associated microvascular complications, warranting further mechanistic and in vivo validation.

Zitieren

APA

Mishra, P., Sharma, D., Wanjari, M. M., Kannojia, P., & Singh, S. B. (2026). Physicochemical Standardization, LC-MS/MS Phytochemical Characterization, and In Vitro Aldose Reductase Inhibitory Activity of Ayurvedic Formulation Chandraprabha Vati. Journal of Integrative and Translational Biomedicine. https://doi.org/10.67316/jintb.v1.i3.57

Vancouver

Mishra P, Sharma D, Wanjari MM, Kannojia P, Singh SB. Physicochemical Standardization, LC-MS/MS Phytochemical Characterization, and In Vitro Aldose Reductase Inhibitory Activity of Ayurvedic Formulation Chandraprabha Vati. Journal of Integrative and Translational Biomedicine. 2026. doi:10.67316/jintb.v1.i3.57

BibTeX
@article{Mishra2026,
  author = {Mishra, Priya and Sharma, Deepti and Wanjari, Manish M. and Kannojia, Pushpendra and Singh, Shyam Babu},
  title = {Physicochemical Standardization, LC-MS/MS Phytochemical Characterization, and In Vitro Aldose Reductase Inhibitory Activity of Ayurvedic Formulation Chandraprabha Vati},
  journal = {Journal of Integrative and Translational Biomedicine},
  year = {2026},
  doi = {10.67316/jintb.v1.i3.57}
}
Kostenlos starten →